Depletion of Flot1 attenuates macropinosome-dependent mTORC1 activation in podocytes

Yanan Li1, Yuxin He1, Longjiao Cheng1

  • 1State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Frontiers Science Center for Cell Responses, Nankai University.

PubMed

Insights

Flotillin-1 (Flot1) is crucial for macropinosome formation and mechanistic target of rapamycin complex 1 (mTORC1) activation in kidney podocytes. This discovery offers new therapeutic targets for podocytopathies.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Podocytes are vital for kidney filtration; their dysfunction causes podocytopathies.
  • Maintaining mechanistic target of rapamycin complex 1 (mTORC1) activation balance is essential for podocyte function.
  • Abnormal mTORC1 activation in podocytes leads to severe kidney disease.

Purpose of the Study:

  • To investigate the molecular mechanism of macropinosome formation in podocytes.
  • To elucidate the role of flotillin-1 (Flot1) in macropinosome formation and mTORC1 activation.
  • To identify potential therapeutic targets for podocytopathies.

Main Methods:

  • Imaging analysis to determine Flot1 localization at circular dorsal ruffles (CDRs).
  • Macropinosome formation assays in Flot1-depleted podocytes.
  • Biochemical analysis of mTORC1 activation in Flot1 knockout (KO) cells.
  • Immunohistochemistry to assess Flot1 expression in renal cells.

Main Results:

  • Flot1 localizes to CDRs, which are precursors to macropinocytosis.
  • Flot1 depletion impairs macropinosome formation and growth factor-stimulated mTORC1 activation.
  • Flot1 is specifically expressed in podocytes, not other kidney cells.
  • Flot1-KO cells exhibit impaired growth compared to controls.

Conclusions:

  • Flotillin-1 is a key mediator of CDR-derived macropinosome formation in podocytes.
  • Flot1 contributes to macropinosome-dependent mTORC1 activation, crucial for podocyte function.
  • Targeting Flot1 may offer a novel therapeutic strategy for podocytopathies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K